Oxford Immunotec Ltd., of Oxford, UK, elected Peter Klemm nonexecutive director and named Frank Vandeputte vice president of sales and marketing...YM BioSciences Inc., of Mississauga, Ontario, added Rogerio C. Lilenbaum and Minesh Mehta to its U.S

Diffusion Pharmaceuticals LLC, of Charlottesville, Va., named David R. Jones chief medical officer and member of its scientific advisory board...GeoVax Labs Inc., of Atlanta, appointed Mark J. Newman vice president of research and development...ImmuCell Corp., of Portland, Maine, added Bobbi Jo Kunde as director of sales and marketing

BIND Biosciences Inc., of Cambridge, Mass., appointed Scott Minick president and CEO...Cel-Sci Corp., of Vienna, Va., appointed Todd S. Burkhart vice president of manufacturing/facilities and commercial operations...CrystalGenomics Inc., of Seoul, South Korea, and CG Pharmaceuticals Inc., of Emeryville, Calif., appointed Eric M. Nelson vice president of business development

operations, Karen Hodgkin head of clinical development and Tina Crombie head of business administration...ConvaTec, of Paris, named Erik Zimmer vice president and general manager within its European, Middle East and Africa region...Sequenom Inc., of San Diego, appointed Kenneth Buechler and David Pendarvis to its board of directors

Senesco Technologies Inc., of New Brunswick, N.J., appointed Jack Van Hulst president and CEO...Siriuis Genomics, of Vancouver, British Columbia, appointed Chris Wagner president and CEO...UCB SA, of Brussels, Belgium, named Ismail Kola executive vice president of UCB and president of UCB New Medicines

team, with Greg Hamilton as chief operating officer and chief financial officer...Suzanne McDonald head of managed markets and government affairs...operations and also appointed Jon Terrett vice president of oncology at its San Jose, Calif

Anesiva Inc., of South San Francisco, named Ted W. Love and David C. U'Prichard to its board, following completion of the merger with Arcion Therapeutics...CellCyte Genetics Corp., of Eastgate, Wash., appointed Douglas Cerretti chief science officer and director of business development...It also appointed Andrew K. W. Powell executive vice president, general counsel and secretary

Oxygen Biotherapeutics Inc., of Durham, N.C., added Rene A. Eckert and William A. Chatfield to its board...Santaris Pharma A/S, of Horsholm, Denmark, added Mark Wedel as vice president and chief medical officer and Stuart Mackey as vice president of strategy and chief business officer

BioAlliance Pharma SA, of Paris, appointed André Ulmann and Denis Biju-Duval to its supervisory board...BrainCells Inc., of San Diego, appointed Edward Scolnick and David Holtzman to its scientific advisory board...DBV Technologies, of Paris, added Gideon Lack and Philippe Eigenmann to its scientific advisory board

BioAlliance Pharma SA, of Paris, appointed André Ulmann and Denis Biju-Duval to its supervisory board...BrainCells Inc., of San Diego, appointed Edward Scolnick and David Holtzman to its scientific advisory board...DBV Technologies, of Paris, added Gideon Lack and Philippe Eigenmann to its scientific advisory board

RetroVirox Inc., of San Diego, appointed Ronald C. Griffith vice president of research and development...Seaside Therapeutics LLC, of Cambridge, Mass., appointed Daniel E. Geffken chief operating officer, John C. Amedio vice president of manufacturing and process development and W. Roger Rush vice president of preclinical development...XOMA Ltd., of Berkeley, Calif., appointed Susan Kramer vice president, project and alliance management

Apthera Inc., of Scottsdale, Ariz., appointed Ira Z. Leiderman executive chairman and named Mary Ann Gray to the board...Dendreon Corp., of Seattle, elected Ian Clark and Pedro Granadillo to its board...NeoStem Inc., of New York, named Teresa Lepore vice president, sales and marketing

Ocular Therapeutix Inc., of Waltham, Mass., named Daniel Myers and Bernard Haffey to its board...Sigma-Aldrich, of St. Louis, appointed George M. Church a director and named George Miller senior vice president, general counsel and secretary

Micromet Inc., of Bethesda, Md., appointed Jan Fagerberg senior vice president and chief medical officer...MorphoSys AG, of Martinsried, Germany, appointed Lisa Rojkjaer vice president and head of clinical development...and promoted David Dodds to president of Sucampo Pharma Europe Ltd

BioMicro Systems, of Salt Lake City, appointed Rob Parry president and chief operating officer...Ironwood Pharmaceuticals Inc., of Cambridge, Mass., named Thomas McCourt chief commercial officer and senior vice president of marketing and sales, and appointed David Ebersman to its board

Spherix Inc., of Bethesda, Md., named Ram R. Nimmagudda director of new business development. Tethys Bioscience Inc., of Emeryville, Calif., promoted Michael Richey to president. Trinity Biosystems, of Menlo Park, Calif., appointed René Castro chief business officer. Vantia Therapeutics, of Southampton, UK, appointed Andrew Crockett vice president of business development. Vivalis, of Nantes, France, appointed Philippe Rousseau chief financial officer.

BiPar Sciences, of San Francisco, appointed G. Kirk Raab chairman and John Schembri as chief financial officer to its TriAct Therapeutics company...EnVivo Pharmaceuticals, of Watertown, Mass., appointed Stephen J. DiPalma senior vice president and chief financial officer...Quanterix Corp., of Cambridge, Mass., appointed David Okrongly CEO and a member of the company's board of directors

AAIPharma Services Corp., of Wilmington, N.C., appointed Christopher Smith vice president of quality and regulatory affairs...Bioheart Inc., of Sunrise, Fla., named Karl E. Groth chairman of the board, Peggy A. Farley chief operating officer and Mark P. Borman chief financial officer...PharmAthene Inc., of Annapolis, Md., appointed Charles A. Reinhart III senior vice president and chief financial officer

Immucor Inc., of Norcross, Ga., named Geoffrey S. Crouse vice president and chief operating officer...Third Rock Ventures LLC, of Boston, appointed Philip R. Reilly and Gregory L. Verdine venture partners, and Craig M. Greaves recruiting partner